Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed?

Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study

(2013) Peter W. G. Tennant et al.   DIABETOLOGIA

Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence

(2012) Janine E. Polifka   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

Obstetric Nephrology: Pregnancy in Women with Diabetic Nephropathy--The Role of Antihypertensive Treatment

(2012) E. R. Mathiesen et al.   Clinical Journal of the American Society of Nephrology

Pregnancy Outcome Following Exposure to Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Antagonists

(2012) Marina Bullo et al.   HYPERTENSION

Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled diabetic retinopathy candesartan trials

(2011) M. Porta et al.   DIABETOLOGIA

Improved Pregnancy Outcome in Type 1 Diabetic Women With Microalbuminuria or Diabetic Nephropathy: Effect of intensified antihypertensive therapy?

(2008) L. Ringholm Nielsen et al.   DIABETES CARE